Nomura Holdings Inc. Takes Position in HealthEquity, Inc. (NASDAQ:HQY)

Nomura Holdings Inc. bought a new stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 11,566 shares of the company's stock, valued at approximately $1,110,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of HQY. Wealthfront Advisers LLC purchased a new stake in shares of HealthEquity during the 4th quarter worth approximately $10,304,089,000. Vanguard Group Inc. lifted its position in HealthEquity by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 8,976,091 shares of the company's stock valued at $861,256,000 after acquiring an additional 99,624 shares during the last quarter. FMR LLC boosted its stake in HealthEquity by 2.4% in the fourth quarter. FMR LLC now owns 5,415,800 shares of the company's stock valued at $519,646,000 after acquiring an additional 125,684 shares in the last quarter. Geode Capital Management LLC boosted its stake in HealthEquity by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 2,089,398 shares of the company's stock valued at $200,522,000 after acquiring an additional 10,421 shares in the last quarter. Finally, Brown Advisory Inc. grew its holdings in shares of HealthEquity by 12.0% during the fourth quarter. Brown Advisory Inc. now owns 2,086,026 shares of the company's stock worth $200,154,000 after purchasing an additional 224,016 shares during the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

HQY has been the topic of a number of recent research reports. The Goldman Sachs Group dropped their price objective on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a research note on Thursday, March 27th. KeyCorp cut their price objective on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a research report on Wednesday, April 16th. Wells Fargo & Company boosted their price target on shares of HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research note on Wednesday, February 26th. Barrington Research reissued an "outperform" rating and set a $112.00 target price on shares of HealthEquity in a research note on Friday, April 11th. Finally, Raymond James raised shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and lowered their price target for the stock from $120.00 to $115.00 in a research note on Tuesday, March 25th. One equities research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, HealthEquity presently has a consensus rating of "Buy" and a consensus price target of $111.75.

Insider Buying and Selling at HealthEquity

In other news, EVP Michael Henry Fiore sold 8,881 shares of the business's stock in a transaction on Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the transaction, the executive vice president now directly owns 56,655 shares of the company's stock, valued at $4,433,820.30. The trade was a 13.55% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Robert W. Selander sold 5,750 shares of the stock in a transaction on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total value of $446,487.50. Following the sale, the director now directly owns 84,969 shares in the company, valued at approximately $6,597,842.85. The trade was a 6.34% decrease in their position. The disclosure for this sale can be found here. Insiders own 2.20% of the company's stock.

HealthEquity Price Performance

Shares of NASDAQ HQY opened at $98.23 on Monday. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The company's 50-day moving average price is $87.88 and its 200 day moving average price is $97.12. HealthEquity, Inc. has a 52 week low of $65.01 and a 52 week high of $115.59. The stock has a market cap of $8.50 billion, a price-to-earnings ratio of 90.12, a PEG ratio of 1.60 and a beta of 0.45.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.